Cargando…
Lesion stage-dependent causes for impaired remyelination in MS
Multiple sclerosis (MS) is the most frequent demyelinating disease and a leading cause for disability in young adults. Despite significant advances in immunotherapies in recent years, disease progression still cannot be prevented. Remyelination, meaning the formation of new myelin sheaths after a de...
Autores principales: | Heß, Katharina, Starost, Laura, Kieran, Nicholas W., Thomas, Christian, Vincenten, Maria C. J., Antel, Jack, Martino, Gianvito, Huitinga, Inge, Healy, Luke, Kuhlmann, Tanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424408/ https://www.ncbi.nlm.nih.gov/pubmed/32710244 http://dx.doi.org/10.1007/s00401-020-02189-9 |
Ejemplares similares
-
Absence of B Cells in Brainstem and White Matter Lesions Associates With Less Severe Disease and Absence of Oligoclonal Bands in MS
por: Fransen, Nina L., et al.
Publicado: (2021) -
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination
por: Mohan, Hema, et al.
Publicado: (2014) -
Beneficial contribution of induced pluripotent stem cell‐progeny to Connexin 47 dynamics during demyelination‐remyelination
por: Mozafari, Sabah, et al.
Publicado: (2020) -
Limited TCF7L2 Expression in MS Lesions
por: Lürbke, Alexander, et al.
Publicado: (2013) -
Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis
por: Starost, Laura, et al.
Publicado: (2020)